Skip to main content
Beat Cancer EU Website Logo
Бариери пред получаването на последващи грижи сред преживелите рак в детска възраст
Дългосрочни грижи за проследяванеВсичкиСтатия

Бариери пред получаването на последващи грижи сред преживелите рак в детска възраст

В тази статия се посочват пречките, с които могат да се сблъскат оцелелите от рак в детска възраст, когато става въпрос за дългосрочно проследяване.

Година:2023

Barriers to Receiving Follow-up Care Among Childhood Cancer SurvivorsLittle is known on why adherence to follow-up care in childhood cancer survivors (CCS) is lacking. This study characterized barriers to adherence to follow-up care among CCS, identified sociodemographic correlates of barriers, and examined whether barriers to follow-up care relate to health-related quality of life. Adult CCS (N=84) were anonymously surveyed via REDCap using the Barriers to Care Questionnaire (BCQ) and the Quality of Life Scale-Cancer Survivor (QOL-CS).

Both descriptive and correlation analyses were conducted. The median BCQ total score was 88.5 (interquartile ranges: 78.4 to 95.7), with the greatest barriers reported in the Skills (eg, ease of navigating the healthcare system) and Pragmatism subscales (eg, cost). There was a statistically significant correlation between the BCQ total score and the QOL-CS total score (rs=0.47, P <0.0001) and the physical, psychological, and social QOL-CS subscales (all P ‘s<0.05).

The results found that barriers to follow-up care for CCS are mostly related to cost and appointment logistics, and that more barriers to care is associated with lower health-related quality of life among CCS. Identifying barriers to follow-up care is the first step in improving adherence, which would allow for earlier detection of late effects of cancer therapy and thereby result in reductions in morbidity and mortality.

Дискусия и въпроси

Забележка: Коментарите са само за дискусия и изясняване. За медицински съвет се консултирайте със здравен специалист.

Оставете коментар

Минимум 10 символа, максимум 2000 символа

Все още няма коментари

Бъдете първият, който ще сподели своето мнение!